Sling Therapeutics hires new CCO
ANN ARBOR–Sling Therapeutics, Inc., a biopharmaceutical company focused on late-stage development of an oral small molecule for the treatment of thyroid eye disease, announced the appointment of Ken Lock as …
Tag: Linsitinib